These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1520 related articles for article (PubMed ID: 21852788)

  • 1. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
    Karran E; Mercken M; De Strooper B
    Nat Rev Drug Discov; 2011 Aug; 10(9):698-712. PubMed ID: 21852788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective: prevention is better than cure.
    Gandy S
    Nature; 2011 Jul; 475(7355):S15. PubMed ID: 21760576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
    Saxena U
    Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
    Sevigny J; Chiao P; Bussière T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; O'Gorman J; Qian F; Arastu M; Li M; Chollate S; Brennan MS; Quintero-Monzon O; Scannevin RH; Arnold HM; Engber T; Rhodes K; Ferrero J; Hang Y; Mikulskis A; Grimm J; Hock C; Nitsch RM; Sandrock A
    Nature; 2016 Sep; 537(7618):50-6. PubMed ID: 27582220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid hypothesis on trial.
    Makin S
    Nature; 2018 Jul; 559(7715):S4-S7. PubMed ID: 30046080
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do beta-amyloid-targeted interventions improve cognition, physical functioning, and overt behaviour of Alzheimer's Disease (AD) patients: Protocol for meta-analysis of Phase 3 clinical trials both completed and terminated.
    Stellick Bedrejo CA; Greenshaw A; Paulden M; Yap S; Marshall RT; Kung JY; Spackman E
    PLoS One; 2024; 19(9):e0307761. PubMed ID: 39331581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.
    Liu J; Yang B; Ke J; Li W; Suen WC
    Drugs Aging; 2016 Oct; 33(10):685-697. PubMed ID: 27699633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amyloid cascade hypothesis has misled the pharmaceutical industry.
    Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.
    Lansbury PT
    Curr Opin Chem Biol; 1997 Aug; 1(2):260-7. PubMed ID: 9667848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and the amyloid cascade hypothesis: ten years on.
    Sommer B
    Curr Opin Pharmacol; 2002 Feb; 2(1):87-92. PubMed ID: 11786314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will anti-amyloid therapies work for Alzheimer's disease?
    St George-Hyslop PH; Morris JC
    Lancet; 2008 Jul; 372(9634):180-2. PubMed ID: 18640437
    [No Abstract]   [Full Text] [Related]  

  • 17. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
    Johnson VE; Stewart W; Smith DH
    Nat Rev Neurosci; 2010 May; 11(5):361-70. PubMed ID: 20216546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroscience. An antibiotic to treat Alzheimer's?
    Helmuth L
    Science; 2000 Nov; 290(5495):1273-4. PubMed ID: 11185394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.
    Wisniewski T; Sadowski M
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S5. PubMed ID: 19090993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.